Regeneron, Teva take aim at Lilly/Pfizer pain drug

Sept 20 (Reuters) - Regeneron Pharmaceuticals Inc

and Israeli drugmaker Teva Pharmaceutical Industries

on Tuesday said they would co-develop Regeneron's experimental

new type of pain drug and...

Read more